Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the joints and can cause persistent inflammation, pain, stiffness, and progressive joint damage.

A meta-analysis of population-based studies estimated the global prevalence of RA at 0.46% or about 460 per 100,000 people between 1980 and 2019.

Because rheumatoid arthritis involves complex interactions between the immune system, inflammatory pathways, genetics, and environmental factors, researchers rely on well-characterized patient-derived biospecimens to investigate disease mechanisms, biomarkers, progression, and treatment responses.

At Bay Biosciences, we understand the importance of clinically characterized specimens for autoimmune disease research. We provide high-quality rheumatoid arthritis biospecimens, including rheumatoid arthritis blood samples, serum, plasma, and other human biospecimens for research and development purposes.

Rheumatoid Arthritis

Understanding Rheumatoid Arthritis

Rheumatoid arthritis is an autoimmune disease in which the immune system mistakenly attacks tissues within the joints.

The resulting inflammatory response primarily affects the synovium, the tissue lining the joints.

Persistent inflammation can cause thickening of the synovium and damage to cartilage, bone, and other joint structures.

Rheumatoid arthritis can affect multiple joints and commonly involves the hands, wrists, and feet. However, the disease can also affect other parts of the body, including the skin, eyes, lungs, heart, and blood vessels.

The biological mechanisms underlying rheumatoid arthritis are complex.

Autoantibodies such as rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs) can occur in affected individuals and are important areas of research.

These characteristics make rheumatoid arthritis biospecimens useful for investigating autoimmune responses, inflammatory pathways, disease-associated biomarkers, and potential therapeutic targets.

Signs and Symptoms of Rheumatoid Arthritis

Rheumatoid arthritis can develop gradually, and symptoms may vary between individuals.

Common signs and symptoms include:

Causes & Risk Factors of Rheumatoid Arthritis

The exact cause of rheumatoid arthritis is not fully understood.

Researchers believe that the disease develops through interactions between genetic susceptibility, immune dysregulation, and environmental factors.

Genetic factors can influence an individual’s susceptibility to rheumatoid arthritis. Certain genetic variants, particularly within the human leukocyte antigen (HLA) region, have been associated with increased disease risk.

The immune system plays a central role in disease development.

Abnormal immune activation can lead to the production of autoantibodies and inflammatory mediators that contribute to synovial inflammation.

Moreover, researchers have pointed out that sex hormones may play a role in the development of rheumatoid arthritis when genetic and environmental factors are also involved.

Studies also show that women are more likely than men to develop rheumatoid arthritis.

Environmental exposures may also influence disease development.

Researchers have also investigated factors such as cigarette smoking, infections, and other exposures that may interact with genetic susceptibility.

Research using autoimmune disease biospecimens can help investigators study the biological mechanisms that contribute to abnormal immune activation and chronic inflammation.

Diagnosis of Rheumatoid Arthritis

Diagnosis generally involves a combination of medical history, physical examination, laboratory testing, and imaging studies.

Healthcare professionals evaluate the number and location of affected joints, the duration of symptoms, and the presence of swelling or tenderness.

Blood tests can provide additional information about autoimmune activity and systemic inflammation.

Rheumatoid factor is one of the antibodies commonly evaluated during rheumatoid arthritis investigations. Anti-citrullinated protein antibodies are another important laboratory marker and can provide additional information about autoimmune activity.

Inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) may also be measured to evaluate systemic inflammation.

Imaging methods such as X-rays, ultrasound, and magnetic resonance imaging (MRI) can help identify joint inflammation, structural abnormalities, and damage.

For researchers, rheumatoid arthritis serum samples and rheumatoid arthritis plasma samples can provide valuable materials for investigating circulating autoantibodies, inflammatory markers, proteins, and other biomarkers.

Treatment of Rheumatoid Arthritis

Treatment aims to control inflammation, reduce symptoms, prevent joint damage, and maintain physical function.

Disease-modifying antirheumatic drugs (DMARDs) are commonly used to control rheumatoid arthritis and reduce disease activity.

Methotrexate is frequently used as an initial DMARD, while other conventional, biologic, and targeted synthetic DMARDs may be used depending on the patient’s disease characteristics and treatment response.

Nonsteroidal anti-inflammatory drugs (NSAIDs) may help reduce pain and inflammation, while corticosteroids can be used in selected situations to control inflammation.

Biologic therapies and targeted treatments can also be used for individuals who require additional disease control. These treatments target specific components of the immune system or inflammatory pathways.

Applications of Rheumatoid Arthritis Biospecimens

Well-characterized rheumatoid arthritis biospecimens can support a wide range of autoimmune and inflammatory disease research applications.

Rheumatoid Arthritis Samples

Rheumatoid arthritis samples allow researchers to thoroughly investigate the biological mechanisms associated with autoimmune joint inflammation.

Rheumatoid Arthritis Blood Samples

Rheumatoid arthritis blood samples can provide several biological components for research.

Whole blood can be processed into plasma, serum, and cellular fractions, helping researchers to investigate both circulating and cellular characteristics of the disease.

These specimens can support studies of immune-cell populations, inflammatory markers, autoantibodies, and other disease-associated factors.

Autoimmune Disease Biospecimens

Autoimmune disease biospecimens can include blood, serum, plasma, tissue, and other patient-derived materials that can be used to compare immune and inflammatory characteristics across autoimmune conditions.

Frequently Asked Questions

What are rheumatoid arthritis biospecimens?

Rheumatoid arthritis biospecimens are patient-derived biological specimens collected from individuals with rheumatoid arthritis.

What are rheumatoid arthritis serum samples used for?

Rheumatoid arthritis serum samples can be used to investigate circulating antibodies and other soluble biomarkers. Researchers may evaluate rheumatoid factor, anti-citrullinated protein antibodies, inflammatory proteins, and other analytes.

Why are rheumatoid arthritis plasma samples useful for research?

Rheumatoid arthritis plasma samples provide access to circulating proteins, immune mediators, nucleic acids, and other biological components. They can support biomarker discovery and studies of systemic inflammation and immune activity.

Are research samples ethically sourced?

Yes. All biospecimens available on our website are sourced with ethical guidelines in mind.

Supporting Your Research with Bay Biosciences

At Bay Biosciences, we provide high-quality biospecimens to pharmaceutical companies, biotechnology organizations, academic institutions, and diagnostic developers. Our comprehensive range of specimens includes:

If you have any questions, concerns, or special requests, please don’t hesitate to contact us.